Next Article in Journal
Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma
Next Article in Special Issue
Excipients in the Paediatric Population: A Review
Previous Article in Journal
The Development and Optimization of Hot-Melt Extruded Amorphous Solid Dispersions Containing Rivaroxaban in Combination with Polymers
Previous Article in Special Issue
Acceptability of a Sublingual Drug Formulation for Respiratory Tract Infections in Children Aged 3 to 5 Years
Article

Adherence and Acceptability of an Oral Antibiotic Used for the Prevention of Pediatric Urinary Tract Infection in Japan

1
National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan
2
ClinSearch, 110 Avenue Pierre Brossolette, 92240 Malakoff, France
*
Author to whom correspondence should be addressed.
Academic Editors: José B. Fariña and Maria Camilla Bergonzi
Received: 16 January 2021 / Revised: 26 February 2021 / Accepted: 4 March 2021 / Published: 6 March 2021
(This article belongs to the Special Issue Development and Adaptation of New and Better Pediatric Drugs)
Urinary tract infection (UTI) is a common health care-associated adverse event and the leading nosocomial complication following pediatric urological surgery. While continuous antimicrobial prophylaxis effectively reduces the risk of UTI following such a surgery, non-adherence is common and represents a distinct clinical entity that is associated with renal scarring. Acceptability is likely to have a significant impact on patient adherence. Herein we used a validated data-driven approach—the ClinSearch acceptability score test (CAST)—to investigate the acceptability of cefaclor, an oral antibiotic widely used for the prevention of pediatric UTI in Japan. Standardized observer reports were collected for 58 intakes of cefaclor 10% fine granules in patients aged from 0 to 17 years. The medicine was classified as positively accepted on the acceptability reference framework. According to the percentage of the prescribed dose taken reported at the end of the treatment, patients exhibited good adherence to this well-accepted medicine. Nonetheless, requirements for greater dosing frequency or poor acceptability in certain patients could affect adherence. Acceptability should be established to ensure patient adherence to medicines used for long-term prophylaxis and consequently guarantee the safety and efficacy of the treatment.
View Full-Text
Keywords: medicine; acceptability; adherence; granules; pediatric; children; formulation; antibiotic; urinary tract infection; ClinSearch acceptability score test (CAST) medicine; acceptability; adherence; granules; pediatric; children; formulation; antibiotic; urinary tract infection; ClinSearch acceptability score test (CAST)
Show Figures

Figure 1

MDPI and ACS Style

Saito, J.; Miyamoto, S.; Yamada, M.; Yamatani, A.; Ruiz, F.; Vallet, T. Adherence and Acceptability of an Oral Antibiotic Used for the Prevention of Pediatric Urinary Tract Infection in Japan. Pharmaceutics 2021, 13, 345. https://0-doi-org.brum.beds.ac.uk/10.3390/pharmaceutics13030345

AMA Style

Saito J, Miyamoto S, Yamada M, Yamatani A, Ruiz F, Vallet T. Adherence and Acceptability of an Oral Antibiotic Used for the Prevention of Pediatric Urinary Tract Infection in Japan. Pharmaceutics. 2021; 13(3):345. https://0-doi-org.brum.beds.ac.uk/10.3390/pharmaceutics13030345

Chicago/Turabian Style

Saito, Jumpei, Sayaka Miyamoto, Mayumi Yamada, Akimasa Yamatani, Fabrice Ruiz, and Thibault Vallet. 2021. "Adherence and Acceptability of an Oral Antibiotic Used for the Prevention of Pediatric Urinary Tract Infection in Japan" Pharmaceutics 13, no. 3: 345. https://0-doi-org.brum.beds.ac.uk/10.3390/pharmaceutics13030345

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop